Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Total Non-Current Liabilities: 2014-2025

Historic Total Non-Current Liabilities for Amphastar Pharmaceuticals (AMPH) over the last 11 years, with Sep 2025 value amounting to $860.2 million.

  • Amphastar Pharmaceuticals' Total Non-Current Liabilities rose 8.82% to $860.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $860.2 million, marking a year-over-year increase of 8.82%. This contributed to the annual value of $824.2 million for FY2024, which is 3.12% down from last year.
  • Amphastar Pharmaceuticals' Total Non-Current Liabilities amounted to $860.2 million in Q3 2025, which was up 3.63% from $830.1 million recorded in Q2 2025.
  • In the past 5 years, Amphastar Pharmaceuticals' Total Non-Current Liabilities registered a high of $933.8 million during Q3 2023, and its lowest value of $181.4 million during Q1 2021.
  • In the last 3 years, Amphastar Pharmaceuticals' Total Non-Current Liabilities had a median value of $830.1 million in 2025 and averaged $778.6 million.
  • In the last 5 years, Amphastar Pharmaceuticals' Total Non-Current Liabilities surged by 350.37% in 2023 and then dropped by 15.35% in 2024.
  • Quarterly analysis of 5 years shows Amphastar Pharmaceuticals' Total Non-Current Liabilities stood at $210.4 million in 2021, then declined by 5.51% to $198.8 million in 2022, then skyrocketed by 328.03% to $850.8 million in 2023, then fell by 3.12% to $824.2 million in 2024, then grew by 8.82% to $860.2 million in 2025.
  • Its Total Non-Current Liabilities was $860.2 million in Q3 2025, compared to $830.1 million in Q2 2025 and $850.6 million in Q1 2025.